Literature DB >> 35879355

Fazirsiran shows promise for liver disease in AAT.

Katrina Ray1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35879355     DOI： 10.1038/s41575-022-00668-w

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   73.082


× No keyword cloud information.
  1 in total

1.  Fazirsiran for Liver Disease Associated with Alpha1-Antitrypsin Deficiency.

Authors:  Pavel Strnad; Mattias Mandorfer; Gourab Choudhury; William Griffiths; Christian Trautwein; Rohit Loomba; Thomas Schluep; Ting Chang; Min Yi; Bruce D Given; James C Hamilton; Javier San Martin; Jeffery H Teckman
Journal:  N Engl J Med       Date:  2022-06-25       Impact factor: 176.079
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.